ResourcesVendorsRoche2841 Scott Blvd Santa Clara, CA, USA 95050Latest from RocheBreast CancerRoche gets FDA approval for metastatic breast cancer CDxThe Pathway anti-HER2 (4B5) test is now FDA-approved for use in the assessment of metastatic breast cancer patients who may be eligible for Enhertu, an HER2-directed antibody drug conjugate.October 4, 2022Roche Request More Info Fill out the form below to request more information about Roche
